… – COVID-19, caused by SARS-CoV-2 infection, has … therapeutic agents against this novel
virus. Hence, the situation demands an immediate need to explore all the plausible therapeutic …

… post-exposure hydroxychloroquine therapy did not prevent SARS-CoV-2 infection in
healthy … ritonavir and chloroquine to model potent anti-SARS-CoV-2 therapy [Citation42,Citation43]. …

… We focus on currently recommended therapeutic agents, … COVID-19 that either show no or
only limited therapeutic activity… demonstrate no efficacy against SARS-CoV-2 infection. Lastly, …

… , and the current status of vaccine and novel therapeutic intervention development. Moreover,
we … to SARS-CoV-2 OMICs and approaches to therapeutics related to COVID-19 treatment. …

… proteases, blocking Coronavirus receptors like an angiotensin-converting enzyme (ACE2), …
therapy, which can bring a revolutionary change to curb the SARS-CoV-2/COVID-19 in the …

… therapies for treating SARS-CoV-2 infection are in progress. In this review, we discuss the
effect of SARS-CoV-2 … therapeutic approaches and vaccines in development to curb the …

… Nevertheless, antibody therapy for SARS-CoV-2 still faces potential … This review summarizes
representative SARS-CoV-2 neutralizing … of COVID-19 preventive or therapeutic antibodies. …

… most crucial target among these critical targets for the development of anti-COVID-19 drugs.
… SARS-CoV-2. We highlight novel inhibitors that were only discovered during the COVID-19 …

… continuous spread of this novel coronavirus in 2019 December in … of SARSCoV-2 virus and
infection disease COVID-19. The doctors have been controlling the virus infection COVID-19 …

… therapy according to what has been learned about the pathophysiology of human SARS-CoV-2 …
preclinical and retrospective study of proposed COVID-19 therapy. Hence, the agents …